These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2428230

  • 1. Basic and clinical cardiac electrophysiology of encainide.
    Mason JW.
    Am J Cardiol; 1986 Aug 29; 58(5):18C-24C. PubMed ID: 2428230
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic actions of O-demethyl encainide: an active metabolite.
    Duff HJ, Dawson AK, Roden DM, Oates JA, Smith RF, Woosley RL.
    Circulation; 1983 Aug 29; 68(2):385-91. PubMed ID: 6861313
    [Abstract] [Full Text] [Related]

  • 3. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ.
    Eur Heart J; 1984 Sep 29; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract] [Full Text] [Related]

  • 4. Qualitative and quantitative comparison of the cardiac effects of encainide and its three major metabolites in the dog.
    Davy JM, Dorian P, Kantelip JP, Harrison DC, Kates RE.
    J Pharmacol Exp Ther; 1986 Jun 29; 237(3):907-11. PubMed ID: 3086540
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of encainide and its two major metabolites on cardiac conduction.
    Dresel PE.
    J Pharmacol Exp Ther; 1984 Jan 29; 228(1):180-6. PubMed ID: 6420542
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute electrophysiologic effects of sodium administration in dogs treated with O-desmethyl encainide.
    Bajaj AK, Woosley RL, Roden DM.
    Circulation; 1989 Oct 29; 80(4):994-1002. PubMed ID: 2551538
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiology of oral encainide.
    Jackman WM, Zipes DP, Naccarelli GV, Rinkenberger RL, Heger JJ, Prystowsky EN.
    Am J Cardiol; 1982 Apr 01; 49(5):1270-8. PubMed ID: 6801954
    [Abstract] [Full Text] [Related]

  • 11. Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent.
    Sami M, Mason JW, Peters F, Harrison DC.
    Am J Cardiol; 1979 Sep 01; 44(3):526-32. PubMed ID: 474433
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic evaluation of encainide with use of monophasic action potential recording.
    Samuelsson RG, Harrison DC.
    Am J Cardiol; 1981 Nov 01; 48(5):871-6. PubMed ID: 6795911
    [Abstract] [Full Text] [Related]

  • 13. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
    Campbell TJ.
    J Cardiovasc Pharmacol; 1983 Nov 01; 5(2):291-6. PubMed ID: 6188905
    [Abstract] [Full Text] [Related]

  • 14. Canine electrophysiology of encainide, a new antiarrhythmic drug.
    Sami M, Mason JW, Oh G, Harrison DC.
    Am J Cardiol; 1979 Jun 01; 43(6):1149-54. PubMed ID: 443174
    [Abstract] [Full Text] [Related]

  • 15. Developmental electrophysiology of encainide and its major metabolites on the Purkinje fiber action potential.
    Case CL, Hewett KW, Gillette PC.
    Biol Neonate; 1994 Jun 01; 66(6):330-8. PubMed ID: 7727615
    [Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic activity of the O-demethyl metabolite of encainide.
    Roden DM, Duff HJ, Altenbern D, Woosley RL.
    J Pharmacol Exp Ther; 1982 Jun 01; 221(3):552-7. PubMed ID: 6806461
    [Abstract] [Full Text] [Related]

  • 17. Temperature and voltage dependence of sodium channel blocking and unblocking by O-demethyl encainide in isolated guinea pig myocytes.
    Johns JA, Anno T, Bennett PB, Snyders DJ, Hondeghem LM.
    J Cardiovasc Pharmacol; 1989 Jun 01; 13(6):826-35. PubMed ID: 2484076
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiology of O-demethyl encainide in a canine model of sustained ventricular tachycardia.
    Roden DM, Dawson AK, Duff HJ, Woosley RL, Smith RF.
    J Cardiovasc Pharmacol; 1984 Jun 01; 6(4):588-95. PubMed ID: 6206311
    [Abstract] [Full Text] [Related]

  • 19. Overview of the clinical pharmacology of antiarrhythmic drugs.
    Woosley RL, Funck-Brentano C.
    Am J Cardiol; 1988 Jan 15; 61(2):61A-69A. PubMed ID: 2447771
    [Abstract] [Full Text] [Related]

  • 20. Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.
    Elharrar V, Zipes DP.
    J Pharmacol Exp Ther; 1982 Feb 15; 220(2):440-7. PubMed ID: 6799644
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.